Carl Zeiss Meditec AG
CZMWY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $628 | $550 | $560 | $491 |
| % Growth | 14.2% | -1.9% | 14.2% | – |
| Cost of Goods Sold | $296 | $260 | $258 | $238 |
| Gross Profit | $716 | $290 | $302 | $252 |
| % Margin | 114% | 52.7% | 53.9% | 51.4% |
| R&D Expenses | $199 | $81 | $76 | $78 |
| G&A Expenses | $37 | $32 | $34 | $28 |
| SG&A Expenses | $170 | $154 | $154 | $149 |
| Sales & Mktg Exp. | $133 | $122 | $119 | $121 |
| Other Operating Expenses | -$108 | $1 | $1 | -$2 |
| Operating Expenses | $261 | $237 | $231 | $224 |
| Operating Income | $166 | $53 | $71 | $28 |
| % Margin | 26.4% | 9.7% | 12.7% | 5.7% |
| Other Income/Exp. Net | -$4 | -$12 | -$6 | -$8 |
| Pre-Tax Income | $67 | $41 | $65 | $20 |
| Tax Expense | $18 | $14 | $20 | $5 |
| Net Income | $66 | $28 | $45 | $16 |
| % Margin | 10.6% | 5.2% | 8.1% | 3.2% |
| EPS | 1.05 | 0.33 | 0.52 | 0.18 |
| % Growth | 218.2% | -36.5% | 188.9% | – |
| EPS Diluted | 1.05 | 0.33 | 0.52 | 0.18 |
| Weighted Avg Shares Out | 88 | 87 | 87 | 87 |
| Weighted Avg Shares Out Dil | 88 | 87 | 87 | 87 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $4 | $2 |
| Interest Expense | $15 | $6 | $7 | $7 |
| Depreciation & Amortization | $77 | $9 | $30 | $9 |
| EBITDA | $215 | $57 | $101 | $37 |
| % Margin | 34.3% | 10.4% | 18% | 7.6% |